Yahoo Finance8 天
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
Detalimogene was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables ...
Yahoo Finance22 天
enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Detalimogene was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and ...
Stockhouse19 天
enGene Announces $60 Million Private Placement Financing
Detalimogene was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of ...
Financial Post19 天
enGene Announces $60 Million Private Placement Financing
Detalimogene was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of ...
Financial Post23 天
enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as ...
Dr. Cheung is a co-founder of enGene and has served in various capacities since the Company’s inception. He has been central to the discovery and development of the Company’s novel and proprietary ...